X

On July 3, 2020 Sanofi Genzyme was notified that our Lemtrada Home Phlebotomy Partner, Examination Management Services Inc., (EMSI) has gone out of business. Because of this, unfortunately, all future Lemtrada Home Phlebotomy (lab draw) visits from EMSI have been cancelled. Patient safety is Sanofi Genzyme’s #1 priority and we are working to provide an alternative phlebotomy solution as well as coordinate alternative testing options for your next monthly lab tests. If you have any questions related to this announcement, please contact your healthcare provider or your One to One Nurse at 1-855-557-2483.

MAT-US-2015317

LEMTRADA is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease, in adults. Since treatment with LEMTRADA can increase your risk of getting certain conditions and diseases, LEMTRADA is generally prescribed for people who have tried 2 or more MS medicines that have not worked well enough. LEMTRADA is not recommended for use in patients with clinically isolated syndrome (CIS). It is not known if LEMTRADA is safe and effective for use in children under 17 years of age.

LEMTRADA is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease, in adults. Since treatment with LEMTRADA can increase your risk of getting certain conditions and diseases, LEMTRADA is generally prescribed for people who have tried 2 or more MS medicines that have not worked well enough. LEMTRADA is not recommended for use in patients with clinically isolated syndrome (CIS). It is not known if LEMTRADA is safe and effective for use in children under 17 years of age.

Information to help discuss relapsing multiple sclerosis treatment options with your doctor

MAKING YOUR DECISION

The decision to start LEMTRADA is a partnership between you, your healthcare provider, your family, and support partners. Find out how to start the conversations.

LEARN MORE


What to expect before starting LEMTRADA treatment for relapsing MS

BEFORE TREATMENT

Before you begin your LEMTRADA treatment, you need to be prepared. Find out what to do to get ready and when you should start preparing for treatment.

GET PREPARED


What to expect during LEMTRADA infusions

DURING TREATMENT

There are steps to follow during a round of LEMTRADA infusions. Find out what you may expect during your treatment days.

SET EXPECTATIONS


What to expect after LEMTRADA Infusion treatment for relapsing MS

AFTER TREATMENT

Taking care of yourself after your infusions are over is very important. See what you should do after your LEMTRADA treatment.

AFTER TREATMENT CARE


Frequently asked questions about LEMTRADA treatment for relapsing MS

FAQs

See some of the Frequently Asked Questions about treatment with LEMTRADA for relapsing MS.

GET ANSWERS


Alex
LEMTRADA
PATIENT

I’m now the
copilot of my
treatment.

That’s
empowering.

See what led Alex to take more control of his treatment decisions.

Learn to perform symptom self-checks

LEARN TO DO SYMPTOM
SELF-CHECKS

Find out how to care for yourself after your LEMTRADA infusions.

The step by step guide to getting started on LEMTRADA treatment

THE STEP BY STEP GUIDE
TO LEMTRADA

Learn what to do before, during, and after treatment. Download now.

Important Safety Information See More

LEMTRADA can cause serious side effects including serious autoimmune problems. Some people receiving LEMTRADA develop a condition where the immune cells in your body attack other cells or organs in the body (autoimmunity), which can be serious and may cause death. Serious autoimmune problems may include: